Investigational Site Number :7240009
Barcelona, Barcelona [Barcelona] 08035
1 studies enrolling now · 3 studies all time
What they study most
Asthma, Chronic Inflammatory Demyelinating Polyneuropathy, Relapsing Multiple Sclerosis
Studies at this site
- A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Recruiting now
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Running, not enrolling
- Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1) — Completed